TEAS Plus New Application

ZYREXAL

Vivera Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88166503
Filing Date: 10/23/2018

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK ZYREXAL
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ZYREXAL
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Vivera Pharmaceuticals, Inc.
*STREET 4533 MacArthur Blvd., #5049
*CITY Newport Beach
*STATE
(Required for U.S. applicants)
California
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
92660
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Marc Hankin
FIRM NAME Hankin Patent Law, APC
STREET 12400 Wilshire Boulevard, Suite 1265
CITY Los Angeles
STATE California
COUNTRY United States
ZIP/POSTAL CODE 90025
PHONE 310-979-3600
EMAIL ADDRESS marc@hankinpatentlaw.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Susan McCain
CORRESPONDENCE INFORMATION
*NAME Marc Hankin
FIRM NAME Hankin Patent Law, APC
*STREET 12400 Wilshire Boulevard, Suite 1265
*CITY Los Angeles
*STATE
(Required for U.S. addresses)
California
*COUNTRY United States
*ZIP/POSTAL CODE 90025
PHONE 310-979-3600
*EMAIL ADDRESS sue@hankinpatentlaw.com; sue@hankinpatentlaw.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
FEE PER CLASS 225
*TOTAL FEE PAID 225
SIGNATURE INFORMATION
* SIGNATURE /Marc E. Hankin/
* SIGNATORY'S NAME Marc E. Hankin
* SIGNATORY'S POSITION Attorney of record, California bar member
SIGNATORY'S PHONE NUMBER 310-979-3600
* DATE SIGNED 10/23/2018



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 88166503
Filing Date: 10/23/2018

To the Commissioner for Trademarks:

MARK: ZYREXAL (Standard Characters, see mark)
The mark in your application is ZYREXAL.


The applicant, Vivera Pharmaceuticals, Inc., a corporation of Delaware, having an address of
      4533 MacArthur Blvd., #5049
      Newport Beach, California 92660
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
       International Class 005:  Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



The applicant's current Attorney Information:
      Marc Hankin and Susan McCain of Hankin Patent Law, APC      12400 Wilshire Boulevard, Suite 1265
      Los Angeles, California 90025
      United States
      310-979-3600(phone)
      marc@hankinpatentlaw.com (authorized)

The applicant's current Correspondence Information:
      Marc Hankin
      Hankin Patent Law, APC
      12400 Wilshire Boulevard, Suite 1265
      Los Angeles, California 90025
      310-979-3600(phone)
      sue@hankinpatentlaw.com;sue@hankinpatentlaw.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Marc E. Hankin/   Date: 10/23/2018
Signatory's Name: Marc E. Hankin
Signatory's Position: Attorney of record, California bar member
Signatory's Phone Number: 310-979-3600
Payment Sale Number: 88166503
Payment Accounting Date: 10/24/2018

Serial Number: 88166503
Internet Transmission Date: Tue Oct 23 20:39:25 EDT 2018
TEAS Stamp: USPTO/FTK-XX.XX.XXX.XXX-2018102320392550
7374-88166503-6103b360bb83b8752df417ea61
96b4705da11cb1abbeb8297dab94b80d2eec9a6-
CC-7320-20181023203809179505

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed